SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-17-000473
Filing Date
2017-05-03
Accepted
2017-05-02 17:46:03
Documents
12
Period of Report
2017-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm 8-K 32437
2 LICENSE AGREEMENT htbx_ex10z2.htm EX-10.2 88255
3 LICENSE AGREEMENT htbx_ex10z3.htm EX-10.3 90493
4 LICENSE AGREEMENT htbx_ex10z4.htm EX-10.4 88146
5 AMENDMENT TO LICENSE AGREEMENT htbx_ex10z5.htm EX-10.5 21340
6 ASSIGNMENT AND ASSUMPTION AGREEMENT htbx_ex10z6.htm EX-10.6 20868
7 SECOND AMENDMENT TO LICENSE AGREEMENT htbx_ex10z7.htm EX-10.7 15996
8 PAYMENT AGREEMENT htbx_ex10z8.htm EX-10.8 20168
9 CANCER RESEARCH GRANT CONTRACT htbx_ex10z9.htm EX-10.9 127504
10 PRESS RELEASE htbx_ex99z1.htm EX-99.1 10991
11 GRAPHIC htbx_ex10z9001.jpg GRAPHIC 18680
12 GRAPHIC htbx_ex10z9002.jpg GRAPHIC 10989
  Complete submission text file 0001553350-17-000473.txt   547800
Mailing Address 801 CAPITOLA DRIVE DURHAM NC 27713
Business Address 801 CAPITOLA DRIVE DURHAM NC 27713 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 17806417
SIC: 2834 Pharmaceutical Preparations